ReachMD publik
[search 0]
Lebih
Unduh Aplikasinya!
show episodes
 
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
  continue reading
 
Loading …
show series
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/new-and-emerging-agents/17863/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal prep quality hinders the clear visualization of …
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/screening-colonoscopy-in-2024-and-beyond/17855/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal prep quality hinders the clear …
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/patient-education-telling-is-not-teaching-and-listening-is-not-learning/17859/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal …
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/dont-flush-another-colonoscopy-down-the-toilet/17860/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal prep quality hinders the …
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/quality-indicators-how-do-you-compare-part-2/17862/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal prep quality hinders the cl…
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/quality-indicators-how-do-you-compare-part-1/17861/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal prep quality hinders the cl…
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/bowel-prep-hesitancy-whats-it-all-about/17857/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal prep quality hinders the clear v…
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/new-frontiers-in-optimizing-patient-outcomes-in-multiple-sclerosis-strategies-for-early-intervention-to-address-progression-independent-of-relapse/16478/ New strategies for early intervention in multiple sclerosis (MS) are focusing on progression ind…
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/bowel-preparation-regimens-how-do-they-compare/17856/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal prep quality hinders the …
  continue reading
 
CME credits: 1.00 Valid until: 20-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/another-inadequate-bowel-prep-it-may-not-be-the-patients-fault/17858/ In the battle against colorectal cancer, inadequate bowel preparation emerges as a critical obstacle compromising the effectiveness of screening colonoscopies. Suboptimal prep qual…
  continue reading
 
CME credits: 0.25 Valid until: 14-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/cracking-the-crs-code-in-myeloma-insights-from-a-comprehensive-case-review/17876/ Bispecific antibodies are the newest immunotherapies approved for heavily pretreated relapsed/refractory myeloma, and they are shown to double response rates. Are you r…
  continue reading
 
CME credits: 1.00 Valid until: 09-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/the-latest-insights-into-rare-blood-disorders-diagnosis-and-treatment-strategies/16630/ Because immune-mediated rare blood disorders are uncommon, healthcare providers often lack the knowledge and experience necessary to identify, diagnose, and treat…
  continue reading
 
CME credits: 0.25 Valid until: 07-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/a-roadmap-to-safe-and-effective-bispecific-antibody-use-in-myeloma-mitigating-and-managing-adverse-events/17875/ Dive into the cutting-edge realm of bispecific antibodies for relapsed/refractory multiple myeloma with our experts, Dr. Caitlin Costello…
  continue reading
 
CME credits: 0.50 Valid until: 07-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/unlocking-the-potential-of-her3-targeted-therapy-breakthroughs-in-egfr-mutant-nsclc-therapeutic-approaches/16214/ Dive into the forefront of precision oncology with Drs. Pasi Janne and Jyoti Patel, where they unravel the potential of HER3-directed an…
  continue reading
 
CME credits: 0.25 Valid until: 07-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/unlocking-the-potential-of-trop2-targeted-therapy-breakthroughs-in-nsclc-therapeutic-approaches/16212/ Drs. Benjamin Levy and Alex Spira discuss the emerging role of TROP2 as a therapeutic target in non-small cell lung cancer (NSCLC) on ReachMD. They…
  continue reading
 
CME credits: 0.25 Valid until: 07-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/unlocking-the-potential-of-her2-targeted-therapy-breakthroughs-in-nsclc-therapeutic-approaches/16213/ Dr. Helena Yu of Memorial Sloan Kettering Cancer Center presents an insightful overview of HER2 targeted therapy in non-small cell lung cancer (NSCL…
  continue reading
 
CME credits: 0.50 Valid until: 05-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/ultrasound-renal-denervation-interdisciplinary-approach-to-better-patient-outcomes/16625/ Dive into the realm of hypertension management through a chapterized expert interview CME activity on ultrasound renal denervation. In the first chapter, explor…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/considerations-for-dosing-bispecific-antibodies/18061/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of hea…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/integrating-bispecific-antibodies-into-clinical-practice/18063/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatme…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/clinical-challenges-with-triple-class-or-penta-refractory-mm/18054/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the tre…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/preventing-crs-and-neurotoxicities-related-to-bispecific-antibodies/18059/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for …
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/the-evolving-treatment-paradigm-for-rrmm-the-role-of-bispecific-antibodies/18056/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodi…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/approved-bispecific-antibodies-for-rrmm-review-of-the-pivotal-trials/18057/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/efficacy-data-for-bispecific-antibodies-in-rrmm/18058/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of hea…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-infections-cytopenias-and-other-aes-related-to-bispecific-antibodies/18060/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antib…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/step-up-dosing-of-bispecific-antibodies-the-need-for-hospitalization/18062/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for…
  continue reading
 
CME credits: 1.00 Valid until: 01-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/bispecific-antibodies-the-newest-immunotherapy-on-the-block-for-rrmm/18055/ "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for…
  continue reading
 
Loading …

Panduan Referensi Cepat